Hiroshi Kawamoto

Hiroshi Kawamoto

Auto-generated profile, based on publicly available information

Hiroshi Kawamoto

Department of Surgery, Graduate School of Medicine, Kyoto University, 606-8507, Kyoto, Japan

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2025 in American Journal of Transplantation
Verified
Journal Article
Open access
KTKosuke Tanaka
Kosuke Tanaka
YUYoichiro Uchida
Yoichiro Uchida
KKKentaro Kadono
Kentaro Kadono
SKShoichi Kageyama
Shoichi Kageyama
HKHiroshi Kawamoto
Hiroshi Kawamoto
EHEtsuro Hatano
Etsuro Hatano
Toll-like Receptor 4 (TLR4) plays a crucial role in ischemia/reperfusion injury (IRI) after liver transplantation (LT). However, the role of TLR4 in the context of steatotic grafts remains unclear. In this study, we developed a mouse model to explore IRI mechanisms in steatotic LT using TLR4 knockout mice as recipients. We successfully transplanted steatotic grafts with approximately 35% macrosteatosis and 5 hours of cold storage. Compared to normal LT, steatotic LT resulted in significantly higher serum level of alanine aminotransferase (ALT) and High Mobility Group Box 1 (HMGB1), higher transcriptional expression of inflammatory markers (C-X-C motif chemokine ligand 2, caspase-1, and caspase-11), and increased infiltration of CD11b-positive cells, correlating with lower survival. Serum HMGB1 and cleaved caspase-3 activation peaked earlier than serum ALT, with cold-stored steatotic grafts releasing more HMGB1. Notably, TLR4 knockout recipients demonstrated improved survival, attenuated inflammatory response, and reduced apoptosis. These findings suggest that TLR4 deficiency in recipients ameliorates IRI in steatotic LT, highlighting the importance of recipient immune modulation in mitigating steatotic graft injury.

11 October 2026 in JGH Open
Verified
Journal Article
Open access
KSKenichi Saga
Kenichi Saga
YUYoichiro Uchida
Yoichiro Uchida
HKHiroshi Kawamoto
Hiroshi Kawamoto
HHHirofumi Hirao
Hirofumi Hirao
YUYosuke Umino
Yosuke Umino
EHEtsuro Hatano
Etsuro Hatano
Background and Aim: Daikenchuto (DKT), a Kampo medicine, is widely used in surgical practice because of its pro‐motility effects on the gastrointestinal tract. Although its anti‐inflammatory effects in the gastrointestinal tract have been well documented, its role in hepatic ischemia–reperfusion injury (IRI) remains unclear. This study investigated the protective effects of DKT and its individual components against hepatic IRI. Methods: Male C57BL/6 mice were fed a diet containing 3.6% DKT or its individual herbal components for 1 week before 60 min of partial hepatic ischemia. Liver injury was evaluated based on serum liver enzyme levels, histology, and TUNEL staining. Portal venous adrenomedullin (ADM) levels and hepatic heme oxygenase‐1 (HO‐1) expression were also assessed. In vitro, peritoneal macrophages were stimulated with High Mobility Group Box 1 (HMGB1) to examine the effects of DKT and 6‐shogaol (6SG). Results: DKT significantly reduced serum alanine aminotransferase levels, necrotic area, and hepatocyte apoptosis compared to the control. Although single‐herb doses equivalent to those in the DKT formula did not confer protection, a threefold dose of processed ginger reproduced the hepatoprotective effects of DKT. DKT did not increase portal ADM levels. In contrast, both DKT and 6SG significantly upregulated HO‐1 expression in vivo and suppressed the production of inflammatory cytokines in HMGB1‐stimulated macrophages in vitro. Conclusion: DKT attenuates liver IRI via HO‐1 induction and suppression of macrophage‐mediated inflammation, rather than via ADM elevation. These protective effects may be mediated, at least in part, by processed ginger.